Food and Drug Administration Approval for Use of Hiberix as a 3-Dose PrimaryHaemophilus influenzaeType B (Hib) Vaccination Series

MMWR. Morbidity and mortality weekly report - United States
doi 10.15585/mmwr.mm6516a3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Centers for Disease Control MMWR Office

Related search

Transparency and Dermatologic Device Approval by the US Food and Drug Administration

JAMA Dermatology
DermatologyMedicine
2018English

Have Thoracic Endografting Outcomes Improved Since US Food and Drug Administration Approval?

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2011English

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients With Intermediate and High-Risk Myelofibrosis

Clinical Cancer Research
Cancer ResearchOncology
2012English

Inclusion of Training Patients in US Food and Drug Administration Premarket Approval Cardiovascular Device Studies

Archives of Internal Medicine
2011English

Food and Drug Administration Drug Approval Summary: Sunitinib Malate for the Treatment of Gastrointestinal Stromal Tumor and Advanced Renal Cell Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2007English

Food and Drug Administration

2003English

Time From US Food and Drug Administration Approval to Publication of Data for Cancer Drugs: A Comparison of First and Subsequent Approvals

Blood Cancer Journal
OncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy